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One of the most common genetic backgrounds for mice used as a model to investigate 
human diseases is the inbred BALB/c strain. This work is aimed to characterize the 
pattern of natural anti-carbohydrate antibodies present in the serum of 20 BALB/c mice 
by printed glycan array technology and to compare their binding specificities with that of 
human natural anti-carbohydrate antibodies. Natural antibodies (NAbs) from the serum 
of BALB/c mice interacted with 71 glycans from a library of 419 different carbohydrate 
structures. However, only seven of these glycans were recognized by the serum of all 
the animals studied, and other five glycans by at least 80% of mice. The pattern of the 
12 glycans mostly recognized by the circulating antibodies of BALB/c mice differed sig-
nificantly from that observed with natural anti-carbohydrate antibodies in humans. This 
lack of identical repertoires of natural anti-carbohydrate antibodies between individual 
inbred mice, and between mice and humans, should be taken into consideration when 
mouse models are intended to be used for investigation of NAbs in biomedical research.
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iNtrODUctiON
Antibody repertoire has marked the success and perpetuity of species. There is a group of circulating 
antibodies known as natural antibodies (NAbs) present in blood at early life without any previ-
ous immunogenic challenge (1, 2). NAbs are spontaneously produced primarily by B-1 cells and 
their levels, and antigen affinities, remain almost constant during lifetime (3). NAbs (mostly IgM) 
are encoded by their genes in germline configuration by B cells, which have not been subjected to 
somatic hypermutation and affinity maturation (4). In fact, at least 80% of the serum IgM, in healthy 
conditions, is produced by this way (5). Little is known about factors involved in the regulation of 
composition of circulating NAbs. Its origin, repertoire, and physiological role are still controversial 
and an issue of continued debate (6).
The most expanded origin hypothesis suggests that stimulation of B-1 lymphocytes is produced by 
exposition to microbiota antigens (7). NAbs were highlighted by the discovery in the early twentieth 
century of the ABO antigen system in human blood. After that, a large group of NAbs has been described 
in humans, which include other alloantibodies related to blood group antigens (Rh, Lewis, etc.), 
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xenoantibodies, and antibodies that target tumor-associated anti-
gens (3, 8). In general, NAbs show a polyreactive binding as they 
react to similar epitopes on a variety of molecular entities (9, 10). 
The maintenance of immune homeostasis through the defense 
against foreign invaders and own damaged/apoptotic cells, 
and the housekeeping removal of cellular debris or metabolite 
clearance, are functions attributed to NAbs (10, 11). Most of 
these antibodies target carbohydrate structures, and have been 
reported to play protective, but also pathogenic roles, in both 
autoimmune and inflammatory diseases (12, 13). Therefore, an 
understanding of the composition and function of the glycan-
reactive NAb repertoire in a healthy condition continues being 
an issue of paramount importance (13).
The Printed Glycan Array (PGA) technology has a high sen-
sitivity and offers the possibility to analyze hundreds of different 
glycan antigens to explore circulating natural anti-carbohydrate 
antibodies in different species (8, 9, 14, 15). This allows the 
minimization of one of the major problems associated with the 
analysis of anti-carbohydrate antibodies; the cross-reactivity of a 
particular antibody with different glycans (16). Mice and specifi-
cally the BALB/c strain is one of the animal species more often 
used as a model of human diseases in both cancer and immunol-
ogy research (17). Although there are previous reports regarding 
global analysis of the natural antibody repertoire (18–20), little 
is known about the exact specificities targeted by natural anti-
carbohydrate antibodies in these animals, and which of them are 
shared with humans. The study presented by Dai et  al. (20) is 
limited to a reduced number of glycan moieties, including four 
representative carbohydrate structures: homo-polysaccharides of 
1,4-linked-d-galactopyranosyluronic acids, 1,6-glucan (dextran), 
1,3-mannan and β-glucan. From these glycan structures, mannan 
was not recognized by serum Abs from any of the mouse and 
rat strains examined and some variability regarding of glycan 
recognition among mice strains under examination was reported. 
Despite this, the authors concluded that IgM reactivity repertoires 
against glycan antigens in rodents are practically homogeneous 
within inbred strains and largely conserved in the species.
The present work is aimed to describe the natural anti-
carbohydrate antibody repertoire of BALB/c mice by PGA, using 
a library of 419 different fully characterized glycan structures, and 




Animals were handled in strict accordance with good animal 
practice as defined by the relevant local animal welfare bodies. 
All animal procedures were supervised and approved by Bellvitge 
Biomedical Research Institute (IDIBELL) ethics committee for 
animal experimentation and the Catalonia Government. The care 
and handling of the animals were conformed to the Guide for the 
Care and Use of Laboratory Animals published by the US National 
Institutes of Health (NIH Publication no. 85-23 revised 1996) and 
the European Agreement on Vertebrate Animal Protection for 
Experimental Use (86/609).
BALB/c Mice
BALB/c mice 10-week-old (Harlan, France), 13 female and 7 
male, were maintained in separated cages at IDIBELL animal 
facility (specific pathogen free, SPF) under controlled conditions 
of temperature (21 ± 1°C), humidity (55 ± 5%), cycles of light/
dark of 12/12 h, and with food and water given ad libitum.
serum collection and Processing
Mice blood extraction was made without the need of anesthesia 
by submandibular bleeding (21). Serum was collected by mild 
centrifugation (10 min, 1,200 g at 4°C) and stored at −80°C for 
further analysis. The human serum was collected from 11 human 
healthy donors, processed and stored under similar condition by 
Semiotik LLC.
Glycan Array Analysis
Glycochips were prepared by Semiotik LLC (Moscow, Russia) 
from 419 different synthetic amine-functionalized glycans, using 
N-hydroxysuccinimide-derivatized glass slides (slide H, Schott-
Nexterion, Mainz, Germany), as described in Ref. (3, 15). The 
glycan library included blood group antigens and some of the 
most frequently occurring terminal oligosaccharides, as well 
as core motifs of mammalian N- and O-linked glycoproteins 
and glycolipids, tumor-associated carbohydrate antigens, and 
polysaccharides from pathogenic bacteria. Synthetic glycan 
structures (>95% purity) are structurally the same as natural 
ones. Structures and NMR data of polysaccharides and related 
references are in http://csdb.glycoscience.ru/bacterial (Zelinsky 
Institute of Organic chemistry, Moscow, Russia). All glycans 
were printed in six replicates. After printing, glycochips were 
incubated in an incubation chamber for 15 min at 25°C with PBS 
plus 0.1% (v/v) Tween-20 (buffer 3) (Sigma-Aldrich, St. Louis, 
MO, USA), and the buffer was then carefully removed from the 
microchip surface using Whatman® filter paper (Sigma-Aldrich, 
St. Louis, MO, USA). BALB/c mouse sera were diluted (1:15) in 
PBS plus 1% (w/v) bovine serum albumin (BSA; Sigma-Aldrich, 
St. Louis, MO, USA) and 1% (v/v) Tween-20 (buffer 1). Diluted 
serum was spread over the slide surface and incubated with 
agitation (30 rpm) at 37°C for 1.5 h. After a round of washing 
steps with buffer 3, buffer 4 (PBS with 0.001% v/v Tween-20), 
and distilled water (Milli-Q grade), the glycochips were drained 
by mild centrifugation (1  min, 175  g, Eppendorf, Hamburg, 
Germany). The glycochips were then incubated for 1 h at 37°C 
(30 rpm) with goat anti-mouse IgG + IgM (H + L) conjugated 
to biotin (Thermo Fisher Scientific, Waltham, MA, USA) and 
diluted 200-fold in PBS plus 1% BSA and 0.1% Tween-20 (buffer 
2). The unbound fraction was removed by repeating the same 
round of washing steps. Glass slides were incubated in darkness 
at 25°C for 45 min (30 rpm) with streptavidin labeled with Cy5 
dye (GE Healthcare, Little Chalfont, Buckinghamshire, UK) 
and diluted 1:500 in buffer 2. After another round of washing, 
the glycochips were dried by airflow in darkness. Finally, the 
glycochips were scanned using a ScanArray GX Plus scanner 
(PerkinElmer, Waltham, MA, USA) with a laser (excitation 
wavelength of 633 nm). All data analysis was performed with the 
ScanArray® Express Microarray Analysis System (PerkinElmer, 
FiGUre 1 | BALB/c mice showed different repertoire of natural circulating anti-carbohydrate antibodies. Mouse (n = 20) serum (1:15) was incubated with chips 
printed with 419 glycans. Chips were scanned using a ScanArray GX Plus reader and data were analyzed with the ScanArray® Express Microarray Analysis System 
(PerkinElmer). The binding results for IgM + IgG were expressed in relative fluorescence units (RFU) as median ± median absolute deviation (MAD). In the heat map, 
blue and white colors represent binding signals, in RFU, lower than 4,000 (background); red color signals ≥4,000 RFU (positive binding). F, female; M, male.
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Waltham, MA, USA). The binding results were expressed in 
relative fluorescence units (RFU) as median ± median absolute 
deviation (MAD). Interactive exploration of multidimensional 
data (heat mapping and clustering analysis) was performed with 
the Hierarchical Clustering Explorer application developed by 
the University of Maryland, MD, USA.1
resULts
To avoid potentially confounding differences in genetic back-
grounds, BALB/c mice were taken from inbred SPF populations 
(Harlan, France). The repertoire of circulating natural anti-
carbohydrate antibodies was studied by PGA technology using 
a library of 419 different glycan structures. Although a previous 
study (22) showed that in normal mouse sera IgM can bind the 
F(ab′)2 of natural IgG autoantibodies, thus the dilution of normal 
serum decreases such IgM anti-IgG autoantibodies and unmasks 
these natural IgG autoantibodies, we have demonstrated that 
this dilution dependent effect is not present in our test system 
(15). Hence, we have used diluted sera (1:15) in all PGA deter-
minations. In the case of mice due to the constraint in the serum 
amount, IgG and IgM anti-carbohydrate antibodies were simul-
taneously determined. Structural identity of polysaccharides was 
confirmed by NMR (deposited in http://csdb.glycoscience.ru/
bacterial). All carbohydrates used in the PGA structurally were 
the same as natural ones. However, density in the slide, length of 
spacer or type of carrier (protein or another polymer, peptide, 
etc.) can influence their activity. Therefore, their presentation 
on the array is quite possibly far from natural presentation 
(23, 24). Nevertheless, this constraint of our in vitro approach had 
1 http://www.cs.umd.edu/hcil/hce/.
no impact on the main objective of our work because both sets of 
PGA determinations (humans and mice) were carried out using 
the same glycan library and conditions; hence, were similarly 
affected.
The data resulting from PGA experiments have been depos-
ited in NCBI GEO Database (25) with the name “Repertoire of 
BALB/c mice natural anti-carbohydrate antibodies,” and are 
accessible through GEO Series accession number GSE97151.2
In the PGA, we considered values above 4,000 RFU as a 
positive signal of antibody binding (this value is ~10% of the top 
glycans RFU), which were expressed as the median  ±  median 
absolute deviation (MAD) (Table S1 in Supplementary Material). 
The majority of printed glycans were not targeted by any natural 
antibody present in the serum of BALB/c mice (Figure 1, in blue), 
and 71 carbohydrates (Figure  1, in red) demonstrated ≥4,000 
RFU in the PGA (see NCBI GEO Database: GSE97151). The 
top rank glycans included 12 with median signal intensities of 
bound antibodies ≥10,000 RFU (Table 1). Seven of them were 
recognized by serum antibodies from all the mice involved in the 
study, while other five glycans were targeted by serum samples of 
at least 80% of animals (Table 1). Sulfated glycans comprised 50% 
of the high-binding glycans and βGal-terminated oligosaccha-
rides 25%. About gender, we did not observe marked differences 
between male and female in the majority of top rank glycans 
listed in Table 1.
Most of the circulating anti-glycan antibodies found in mice 
were not widely represented in the human sera, as the number 
of human donors showing signals ≥4,000 RFU in the PGA was 
limited or absent for the major part of these top rank glycan 
structures (Table  1). Concomitantly, the high level circulating 
anti-glycan antibodies found in humans (Table 2) were poorly 
2 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97151.
tABLe 2 | Specificity of carbohydrates targeting natural antibodies in humans.
Glycan iD (#) structure common name Number of human donors showing 
rFU ≥4,000 (%)
Number of mice showing  
rFU ≥4,000 (%)
igM igG
019 ManNAcβ-spa 91 91 20
080 Galα1-3GlcNAcβ-sp 82 82 0
082 Galα1-4GlcNAcβ-sp αLN 73 73 5
101 GalNAcα1-3GalNAcβ-sp Fs-2 82 91 5
149 GlcNAcβ1-4(6-O-Su)GlcNAcβ-sp 82 82 25
246 GlcNAcβ1-2Galβ1-3GalNAcα-sp 91 82 0
256 GlcNAcβ1-6(GlcNAcβ1-4)GalNAcα-sp 91 91 40
278 GalNAcα1-3GalNAcβ1-3Galβ-sp Fs-3 73 82 n.d
375 Galα1-4GlcNAcβ1-3Galβ1-4GlcNAcβ-sp 73 73 5
378 Galβ1-3GlcNAcα1-3Galβ1-4GlcNAcβ-sp 82 73 45
399 Galβ1-3GlcNAcα1-3Galβ1-3GlcNAcβ-sp 82 82 50
806 Galα1-6Glcα-sp 82 73 20
808 Galα1-6Glcβ-sp Melibiose 91 73 35
List of glycans with binding signals above 4,000 relative fluorescence units (RFU) for both, IgM and IgG antibodies in at least 70% of human donors (n = 11). Comparison with mice 
data (n = 20). The data obtained by Semiotik LLC, Russia, in the same conditions.
asp means aminoethyl, aminoprolyl, or glycyl spacer.
n.d, not determined.
tABLe 1 | Specificity of carbohydrates targeting natural antibodies in BALB/c mice.
Glycan iD (#) structure common name Median and 
MAD as rFU
Number of mice showing  
rFU ≥4,000 (%)
Number of human donors 
showing rFU ≥4,000 (%)
igM igG
060 6-O-Su-Galβ-spa 61,113 1,156 100 73 0
271 Galβ1-6Galβ1-4Glcβ-sp 53,622 1,934 100 55 27
802 Galβ1-3GalNAc(fur)β-sp 51,348 2,324 100 73 9
176 3-O-Su-Galβ1-4(6-O-Su)Glcβ-sp 43,008 9,342 100 9 0
166 GlcAβ1-6Galβ-sp 39,105 2,993 85 18 0
150 3-O-Su-Galβ1-3GalNAcα-sp 37,943 3,232 100 18 0
437 GalNAcα1-3(Fucα1-2)Galβ1-3GalNAcβ-sp A(type 4) 33,886 3,193 90 45 45
125 6-Bn-Galβ1-4GlcNAcβ-sp 32,674 5,389 95 0 0
154 3-O-Su-Galβ1-3GlcNAcβ-sp 32,651 3,954 100 64 36
177 3-O-Su-Galβ1-4(6-O-Su)GlcNAcβ-sp 32,496 7,215 100 9 9
287 3-O-Su-Galβ1-3(Fucα1-4)GlcNAcβ-sp SuLea 20,063 4,962 95 0 9
234 Galβ1-4(Fucα1-3)GlcNAcβ-sp Lex 13,573 2,635 80 0 0
List of glycans with binding signals above 4,000 relative fluorescence units (RFU) in at least 80% of examined mice (n = 20). Comparison with human data (n = 11). The data 
obtained by Semiotik LLC, Russia, in the same conditions.
asp means aminoethyl, aminoprolyl, or glycyl spacer.
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represented among the animals assessed. Additionally, humans 
showed, like mice, significant variability between individuals 
in the level and diversity of circulating anti-glycan antibodies 
(Figure 2; Table S2 in Supplementary Material).
DiscUssiON
Murine and specifically BALB/c mice are among the most widely 
used inbred strains for animal experimentation to address almost 
every aspect of human health (17). This work demonstrates that 
genetically identical SPF mice should not be considered as “totally 
equivalents” from the immunological view as they present, 
despite some conservatism, different patterns of natural circulat-
ing anti-carbohydrate antibodies, which also differ dramatically 
from the conserved anti-carbohydrate antibody repertoire found 
in humans. Previous global analysis of natural antibody reper-
toires has revealed a marked conservation of reactivity patterns 
within inbred mouse strains (18–20). However, some of these 
studies must be analyzed with caution due to the limited number 
of glycans assessed (20). This homogeneity among genetically 
identical animals was not observed in our study (25), and could 
be explained by the differences demonstrated in the analysis 
of the gut microbial population of inbred animals (26). If the 
production of natural anti-carbohydrate antibodies is triggered 
by the antigenic stimulation of microbiota, and this is different 
among inbred mice, fine specificity of these antibodies will not 
be identical.
There are also significant differences between mice and humans 
regarding the primary glycan specificities targeted by natural anti-
carbohydrate antibodies. The discrepancy in repertoires is quite 
evident if top rank carbohydrates recognized by mice antibodies 
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are directly compared with the top rank of circulating anti-glycan 
antibodies in humans (3). This disparity cannot be attributed to 
alloantibodies because in humans anti-blood group antibodies 
(like anti-A, anti-B, anti-Lewis) are not top rank immunoglobu-
lins (3). The most intriguing appear to be the rather high level of 
anti-LeX in BALB/c mice. In humans, healthy donors never have 
antibodies to LeX epitope, Galβ1-4(Fucα1-3)GlcNAcβ, as well as 
to related so-called type 2 motif containing antigens (i.e., struc-
tures with Galβ1-4GlcNAc core) like LeY and SiaLeX. The absence 
of these antibodies in humans is easy to explain: LeX termination 
is known as the structure of many glycoproteins and glycolipids 
of endothelial and blood group cells membrane. In contrast to 
humans, 80% of BALB/c mice demonstrated moderate levels of 
anti-LeX antibodies. The “moderate” means a level comparable 
or higher than, for example, titers of anti-A/B alloantibodies, or 
anti-αGal xenoantibodies, which cause hemolytic reactions or 
organ rejection in humans. In mice, LeX is known as stage-specific 
embryonic antigen-III and plays a crucial role in neurogen-
esis, embryogenesis, and reproduction system (27, 28). Why in 
BALB/c mice the antibodies coexist with cognate antigen without 
immunologic attack remains unclear. Notably, other mice strains 
(29) also found to have anti-LeX NAbs, with an apparent func-
tion to protect from Schistosoma parasites (30). Concurrently, 
top anti-glycan antibodies conserved among humans (3, 8), such 
as GlcNAcβ-terminated, GlcNAcα-terminated, Rha, LeC, Fs/Adi, 
asialo-GM1, and Fucα1-3(4)GlcNAc, are completely missing in 
mice, or, like in case of anti-blood group P1 and Pk trisaccharides, 
at very low level. Although we show with the glycan array that 
BALB/c and human IgM have different glycan binding specifici-
ties, these differences may not significantly alter the functional 
effect of human or mouse IgM on murine cells as shown in prior 
studies (31–33).
FiGUre 2 | Humans showed different repertoire of natural circulating anti-carbohydrate antibodies. Human (n = 11) serum (1:15) was incubated with chips printed 
with 419 glycans. Chips were scanned using a ScanArray GX Plus reader and data were analyzed with the ScanArray® Express Microarray Analysis System 
(PerkinElmer). The binding results for IgM and IgG were expressed in relative fluorescence units (RFU) as median ± median absolute deviation (MAD). In the heat 
map blue and white colors represent binding signals, in RFU, lower than 4,000 (background); red color signals ≥4,000 RFU (positive binding).
The differences observed in the repertoire of anti-carbohydrate 
antibodies in genetically identical BALB/c mice, and between 
these mice and humans, also reflect the uncertainties about the 
functional role and origin of NAbs. Three hypotheses attempt to 
explain the development of these antibodies (6). The first sug-
gests the specific stimulation by new antigens of the bacterial 
microbiota; the second is based on the response to endogenous 
degradation products of normal cells, not to neoantigens; and the 
third proposes that NAbs result from the exposure to molecular 
patterns. The latter are different conserved molecules located 
close to each other that can be divided into two groups: MAMPs, 
microorganism associated molecular patterns, composed of poly-
saccharides, and DAMPs, damage associated molecular patterns, 
constituted by proteins. In the case of polysaccharides, human 
anti-glycan antibodies, including anti-A/B allo-agglutinins, 
antibodies to glycoprotein O-chain glycans Galβ1-3GalNAcα 
(TF) and GalNAcα (Tn), are risen due to contact of the newborn 
immune system with intestinal microbiota (34, 35). Pivotal 
role in this phenomenon might play bacterial polysaccharides, 
structure of which mimics ABH blood groups (7, 36), TF/Tn or 
other related mammalian glycans (37, 38). From the moment of 
birth, the gastrointestinal tract and respiratory system in mam-
mals are actively colonized by bacteria. About 103 species of 
non-pathogenic (commensal) bacteria form the basis of normal 
intestinal microbiota (39), although the total number of species 
is estimated to be greater. These bacteria possess millions of 
antigens, and they are capable to prime those B-1 lymphocytes 
which are genetically selected for the synthesis of NAbs (6, 40). 
It was shown that up to 90% of the immunoglobulin-secreting 
cells of the normal mouse intestine produce natural Abs that 
are absent in germ-free mice (41, 42). Thus, the appearance of 
a particular natural anti-carbohydrate antibody requires “two 
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keys”—the existence of B-1 cell gene and the priming with bacte-
rial antigen (a mimotope of the cognate antigen). Bacteria are 
the best source for anti-carbohydrate antibody priming for two 
additional reasons: (1) appearance only after birth, (2) the need 
of toll-like receptors for recognition by B-1 cells; this mechanism 
excludes priming of B-1 cells with auto-antigens at the embryonic 
stage (6). Genetics of B-cells, as well as microbiotas of humans 
and mice are different, so it is not surprising that the resulting 
repertoires of NAbs are not similar. At the same time, since some 
of the NAbs (for instance, anti-A/B) play a similar physiologically 
active role, they are similar in different species.
In summary, the results presented here indicate that the rep-
ertoires of circulating natural anti-glycan antibodies in BALB/c 
mice appear to be not identical for genetically identical individual 
animals. Additionally, mice antibody repertoire shows significant 
differences to that present in humans, suggesting a caution when 
using mice as an animal model for investigation of human NAbs 
for biomedical studies.
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